147 related articles for article (PubMed ID: 19840141)
1. Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis.
Troidle L; Finkelstein F; Hotchkiss M; Leypoldt JK
Hemodial Int; 2009 Oct; 13(4):487-91. PubMed ID: 19840141
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of phosphorus during hemodialysis and the calculation of its effective dialysis clearance.
Schück O; Kaslikov J
Clin Nephrol; 1997 Jun; 47(6):379-83. PubMed ID: 9202868
[TBL] [Abstract][Full Text] [Related]
3. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
[TBL] [Abstract][Full Text] [Related]
4. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
Kohn OF; Coe FL; Ing TS
Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
[TBL] [Abstract][Full Text] [Related]
5. A thrice weekly in-center nocturnal hemodialysis program.
Troidle L; Hotchkiss M; Finkelstein F
Adv Chronic Kidney Dis; 2007 Jul; 14(3):244-8. PubMed ID: 17603977
[TBL] [Abstract][Full Text] [Related]
6. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.
Tonelli M; Wang W; Hemmelgarn B; Lloyd A; Manns B;
Am J Kidney Dis; 2009 Dec; 54(6):1108-15. PubMed ID: 19619920
[TBL] [Abstract][Full Text] [Related]
7. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
[TBL] [Abstract][Full Text] [Related]
8. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
9. [Factors which influence phosphorus removal in hemodialysis].
Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
[TBL] [Abstract][Full Text] [Related]
10. Beta2-microglobulin and phosphate clearances using a wearable artificial kidney: a pilot study.
Gura V; Davenport A; Beizai M; Ezon C; Ronco C
Am J Kidney Dis; 2009 Jul; 54(1):104-11. PubMed ID: 19376616
[TBL] [Abstract][Full Text] [Related]
11. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments.
Leypoldt JK; Cheung AK; Deeter RB; Goldfarb-Rumyantzev A; Greene T; Depner TA; Kusek J
Kidney Int; 2004 Oct; 66(4):1669-76. PubMed ID: 15458465
[TBL] [Abstract][Full Text] [Related]
13. [Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels].
Tuccillo S; Bellizzi V; Catapano F; Di Iorio B; Esposito L; Giannattasio P; Maione E; Mangiacapra S; Minutolo R; Zamboli P; Conte G; De Nicola L
G Ital Nefrol; 2002; 19(4):439-45. PubMed ID: 12369047
[TBL] [Abstract][Full Text] [Related]
14. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
[TBL] [Abstract][Full Text] [Related]
15. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
16. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
Pellicano R; Polkinghorne KR; Kerr PG
Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
[TBL] [Abstract][Full Text] [Related]
17. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
18. Phosphorus dynamics during hemodialysis.
Kjellstrand CM; Ing TS; Kjellstrand PT; Odar-Cederlof I; Lagg CR
Hemodial Int; 2011 Apr; 15(2):226-33. PubMed ID: 21352467
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
Kawanishi H; Moriishi M; Tsuchiya S
Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
[TBL] [Abstract][Full Text] [Related]
20. Once-weekly hemodialysis helps continuous ambulatory peritoneal dialysis patients who have insufficient solute removal.
Kanno Y; Suzuki H; Nakamoto H; Okada H; Sugahara S
Adv Perit Dial; 2003; 19():143-7. PubMed ID: 14763051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
